PHARMATHENE, INC·4

May 10, 9:57 PM ET

MORGES WAYNE 4

4 · PHARMATHENE, INC · Filed May 10, 2010

Insider Transaction Report

Form 4
Period: 2010-05-06
MORGES WAYNE
VP, Regulatory Affairs & Qual
Transactions
  • Award

    Stock Option (right to buy)

    2010-05-06+75,00075,000 total
    Exercise: $1.38Exp: 2020-05-06Common Stock (75,000 underlying)
Footnotes (2)
  • [F1]On May 6, 2010, the date such options were granted, the closing price of the Issuer's Common Stock on the NYSE Amex was $1.38 per share.
  • [F2]The option vests over a 4 year period with 25% each vesting on the first, second, third and fourth anniversaries of the grant date.

Documents

1 file
  • 4
    v184296_ex.xmlPrimary